ASRM 2025

CaseBioscience will attend and exhibit at the American Society for Reproductive Medicine, ASRM 2025 Annual Meeting, to be held October 25–29, 2025, in San Antonio, Texas.

As a manufacturer of chemically defined, animal-component-free stem cell culture and cryopreservation media, CaseBioscience is committed to supporting advances in Assisted Reproductive Technology (ART). At ASRM 2025, the company will feature its next-generation media portfolio designed to enhance workflow efficiency and consistency across embryology and fertility laboratories.

“CaseBioscience has invested deeply in developing robust and regulatory-compliant media platforms to support ART professionals in delivering the highest standard of care,” said Kevin Flynn, Chief Scientific Officer. “ASRM 2025 provides an important opportunity to meet with colleagues, exchange insights, and discuss how our solutions can contribute to improved clinical and research outcomes.”

The CaseBioscience team will be available throughout the meeting to speak with clinicians, embryologists, and researchers about:

• Culture Media Solutions that maintain high reproducibility and reliability across ART procedures.

• Cryopreservation Technologies including DMSO-free formulations designed to improve cell viability and patient safety.

• Custom Media Services that provide tailored development and optimization to meet specific laboratory needs.

CaseBioscience operates from an ISO 13485:2016-certified facility and applies rigorous quality standards, including USP sterility and endotoxin testing, to ensure product safety and consistency. By integrating decades of expertise in embryo culture and cryobiology, the company is advancing tools that bridge clinical practice and translational research in reproductive medicine.

CaseBioscience looks forward to meeting with ASRM participants to discuss collaboration opportunities and share its vision for the future of ART.